Results 111 to 120 of about 157,760 (344)
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk+12 more
wiley +1 more source
A Study of the Mechanism of Secretion of the Sodium-Retaining Hormone (Aldosterone)12 [PDF]
John H. Laragh, H. C. Stoerk
openalex +1 more source
Background: Higher levels of ideal cardiovascular health (ICH) are associated with lower levels of aldosterone and incidence of cardiovascular disease (CVD).
Bjorn Kluwe+15 more
doaj
Abstract Aims Cardiac decompensation in cardiorenal syndrome (CRS) results in systemic congestion usually treated with diuretics. When despite high doses of diuretics, response is poor, ultrafiltration (UF) appears to be a useful and safe technique.
Borja Guerrero Cervera+12 more
wiley +1 more source
ADJUSTMENT TO ALDOSTERONE OR DESOXYCORTICOSTERONE ACETATE INDUCED SODIUM RETENTION IN PATIENTS WITH ADDISON'S DISEASE * [PDF]
J. T. August, Don H. Nelson
openalex +1 more source
eGFR slope as predictor of mortality in heart failure patients
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken+10 more
wiley +1 more source
EFFECT OF ALDOSTERONE ON RENAL EXCRETION OF INTRAVENOUSLY ADMINISTERED SALINE1 [PDF]
D. F. Cole
openalex +1 more source
The Differential Effect of Excess Aldosterone on Skeletal Muscle Mass by Sex
The effects of excess aldosterone on skeletal muscle in individuals with primary aldosteronism (PA) are unknown. To examine the effects of aldosterone on skeletal muscle mass in patients with PA, by sex, 309 consecutive patients were enrolled.
Mi Kyung Kwak+9 more
doaj +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant+17 more
wiley +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh+18 more
wiley +1 more source